United States - English - NLM (National Library of Medicine)

pacira pharmaceuticals inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - injection, lipid complex - 10 mg in 1 ml - depodur is an extended-release liposome injection of morphine sulfate intended for single-dose administration by the epidural route, at the lumbar level, for the treatment of pain following major surgery. depodur is administered prior to surgery or after clamping the umbilical cord during cesarean section. depodur is not intended for intrathecal, intravenous, or intramuscular administration. administration of depodur into the thoracic epidural space or higher has not been evaluated and therefore is not recommended. depodur is contraindicated in patients with known hypersensitivity to morphine, morphine salts, or any components of the product. depodur, as with all opiates, is contraindicated in patients with respiratory depression, acute or severe bronchial asthma, and upper airway obstruction. any contraindications for an epidural injection preclude the administration of depodur. depodur, as with all opiates, is contraindicated in any patient who has or is suspected of having paralytic ileus. depodur should n

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - norfloxacin 400mg;   - film coated tablet - 400 mg - active: norfloxacin 400mg   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry white oy-b-28920 amb purified water - upper and lower, complicated and uncomplicated acute urinary tract infections including cystitis, pyelitis, cystopyelitis, pyelonephritis, chronic prostatitis, epididymitis, and those urinary infections associated with urologic surgery, neurogenic bladder or nephrolithiasis caused by bacteria susceptible to norfloxacin;

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ceftazidime pentahydrate 1 g - powder for injection - 1 g - active: ceftazidime pentahydrate 1 g excipient: sodium carbonate - treatment of single or multiple infections caused by susceptible organisms. may be used alone as first choice medicine before the results of sensitivity tests are available. may be used in combination with an aminoglycoside or most other ?- lactam antibiotics. may be used with an antibiotic against anaerobes when the presence of bacteroides fragilis is suspected.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ceftazidime pentahydrate 2 g - powder for injection - 2 g - active: ceftazidime pentahydrate 2 g excipient: sodium carbonate - treatment of single or multiple infections caused by susceptible organisms. may be used alone as first choice medicine before the results of sensitivity tests are available. may be used in combination with an aminoglycoside or most other ?- lactam antibiotics. may be used with an antibiotic against anaerobes when the presence of bacteroides fragilis is suspected.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ceftazidime pentahydrate 500mg - powder for injection - 500 mg - active: ceftazidime pentahydrate 500mg excipient: sodium carbonate - treatment of single or multiple infections caused by susceptible organisms. may be used alone as first choice medicine before the results of sensitivity tests are available. may be used in combination with an aminoglycoside or most other ?- lactam antibiotics. may be used with an antibiotic against anaerobes when the presence of bacteroides fragilis is suspected.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - tobramycin 28mg - powder filled inhalation capsule - 28 mg - active: tobramycin 28mg excipient: butyl alcohol calcium chloride dihydrate carnauba wax carrageenan distearoyl-dl-phosphatidylcholine hypromellose indigo carmine aluminium lake isopropyl alcohol potassium chloride propylene glycol shellac sulfuric acid titanium dioxide water for injection - management of cystic fibrosis patients with pseudomonas aeruginosa infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime sodium 262.5mg equivalent to 250 mg cefuroxime - powder for injection - 250 mg - active: cefuroxime sodium 262.5mg equivalent to 250 mg cefuroxime

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime axetil 150.36mg equivalent to 125 mg cefuroxime - film coated tablet - 125 mg - active: cefuroxime axetil 150.36mg equivalent to 125 mg cefuroxime excipient: colloidal silicon dioxide croscarmellose sodium hydrogenated vegetable oil hypromellose methyl hydroxybenzoate microcrystalline cellulose opaspray white m-1-7120 propyl hydroxybenzoate propylene glycol sodium laurilsulfate

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - cefuroxime axetil 300.72mg equivalent to 250 mg cefuroxime - film coated tablet - 250 mg - active: cefuroxime axetil 300.72mg equivalent to 250 mg cefuroxime excipient: colloidal silicon dioxide croscarmellose sodium hydrogenated vegetable oil hypromellose methyl hydroxybenzoate microcrystalline cellulose opaspray white m-1-7120 propyl hydroxybenzoate propylene glycol sodium laurilsulfate - cefuroxime axetil is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime, which is resistant to most beta-lactamases and is active against a wide range of gram-positive and gram-negative organisms. zinnat is indicated in adults and children aged two years or older for the treatment of infections caused by sensitive bacteria. susceptibility to cefuroxime axetil will vary with geography and time, and it should be used in accordance with local official antibiotic prescribing guidelines and local susceptibility data.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime axetil 601.44mg equivalent to 500mg cefuroxime - film coated tablet - 500 mg - active: cefuroxime axetil 601.44mg equivalent to 500mg cefuroxime excipient: colloidal silicon dioxide croscarmellose sodium hydrogenated vegetable oil hypromellose methyl hydroxybenzoate microcrystalline cellulose opaspray white m-1-7120 propyl hydroxybenzoate propylene glycol sodium laurilsulfate